摘要
目的 观察力尔凡加化疗治疗恶性胸腹水的疗效。方法 3 6例胸腹水患者 ,胸水 2 6例 ,腹水 10例 ,合并胸水者持续放胸水后 ,注入PDD 5 0mg ,力尔凡 10mg ,每周一次 ;合并腹水者 ,放出一定量的腹水后 (<2 0 0 0ml) ,注入MMC 10mg或 5 -FU 10 0 0mg ,力尔凡 10mg ,每周 2次。结果 控制胸水CR 18例 ,PR 6例 ,有效率 92 3 % ;腹水CR 3例 ,PR 3例 ,有效率 60 %。结论 力尔凡联合化疗能有效控制胸腹水 ,对化疗有增效减毒作用 ,提高患者生存质量 。
Objective To evaluate the effect of Lifein combined with chemotherapy in the treatment of malignant pleural effusiong and ascites.Method Of 36 cases,26 cases with malignant pleural effusion and 10 cases with ascites,after completely giving out pleural effusion were injected PDD 50 mg and Lifein 10 mg evey week,and injected MMC 10 mg or 5 FU 1000 mg and Lifein 10 mg after letting out a little ascites (<2000 ml every time) two times every week.Results The effective rate in controlling pleural effusion was 92.3%,in controlling ascites was 60%.Conclusion Lifein can effectively control the malignant pleural effusion and ascites,reduce the side effects of chemotherapy,improve the effects of chemotherapy and the patient's quality of life.No serious toxicity of side effect was observed.
出处
《河南肿瘤学杂志》
2002年第1期39-40,共2页
Henan Journal of Oncology
